CEPD N.V.:
REJECTS DOCMORRIS MISCHARACTERISATION AND EMPHASIZES CASE FOR REAL GOVERNANCE REFORM
DOES NOT PLAN A TAKEOVER OF DOCMORRIS
Shareholder CEPD Says It Rejects DocMorris' Mischaracterisation And Emphasizes Case For Real Governance Reform
Watch DocMorris' latest callDocMorris (SIX Swiss: DOCM) Q1 2026 Earnings Call · Replay · Apr 16Read the transcript of DocMorris (SIX Swiss: DOCM) Q1 2026 Earnings CallIn the deck
Earlier from DocMorris
- DocMorris enhances its leading AI-powered health platform by partnering with Hello Inside to address metabolic healthcare
- CEPD N.V Proposes To AGM Of DocMorris Major Renewal Of Board Of Directors
- DOCM: Strong Rx and digital growth, margin expansion, and Google partnership set up 2026 EBITDA breakeven
- DocMorris AG announces changes to its Board of Directors
- DocMorris receives TÜV certification for temperature-controlled delivery of pharmaceuticals
Later from DocMorris
- 2026 Annual General Meeting: Strong vote by shareholders in favour of continuity in leadership and strategy
- Stiftung Warentest tests online pharmacies: DocMorris comes out on top
- Online pharmacy DocMorris launches AI-driven cost-savings programme, cuts 100 jobs
Follow DocMorris into a list and get an email when it puts out news.
Follow DocMorris